作者: Pieter Colin , Lieselotte De Smet , Chris Vervaet , Jean-Paul Remon , Wim Ceelen
DOI: 10.1007/S11095-014-1384-5
关键词:
摘要: Purpose A strong pharmacokinetic rational exists for the use of (Hyperthermic) Intraperitoneal Perioperative Chemotherapy in peritoneal carcinomatosis. However, controversy remains regarding optimal treatment strategies. Paclitaxel is believed to be a good compound IPEC because its favourable properties.